Clinical data highlights advantages of protected PCI to enable complete revascularization
New research adds to 12 years of real-world data and FDA studies demonstrating the use of Abiomed's Impella heart pumps during high-risk PCI enables skilled interventional cardiologists to achieve more complete revascularization, improved ejection fraction and quality of life. April 23, 2019